Smilaxchinoside F Isolation via Multi-Step Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for isolating and purifying compounds from Smilax china L rhizome are inefficient, and there is a lack of effective compounds for treating diseases related to angiogenesis such as diabetic retinopathy, atherosclerosis, rheumatoid arthritis, and tumor diseases.
Innovation Solution
A new compound, Smilaxchinoside F, is extracted and purified using a multi-step chromatography process involving organic solvents, DM130 macroporous resins, MCI gel filtration chromatography, and Sephadex LH-20 gel filtration chromatography, demonstrating its potential therapeutic applications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional extraction and separation methods are used for isolating compounds from Smilax china L rhizome, then the process is simple, but the efficiency and productivity are low
Solution Approach 1:
The separation process is divided into multiple sequential steps: organic solvent extraction, macroporous resin adsorption, MCI gel filtration chromatography, and Sephadex LH-20 gel filtration chromatography. Each step segments the mixture to isolate specific compounds based on their physical and chemical properties, thereby improving productivity while managing complexity through systematic division of the separation task
Solution Approach 2:
Multiple intermediary separation media are employed including DM130 macroporous resins, MCI gel filtration chromatography medium, and Sephadex LH-20 gel filtration chromatography medium. These intermediaries facilitate the stepwise purification process by providing selective interaction mechanisms for different compound classes, enhancing isolation efficiency without requiring a single complex separation system
2Productivity
If multiple chromatography techniques are employed to improve separation efficiency, then the productivity increases, but the device complexity and process difficulty increase
Solution Approach 1:
The complex separation is segmented into four distinct chromatographic steps, each targeting specific compound fractions. This segmentation allows systematic purification while maintaining manageable process complexity through clear stepwise progression from crude extract to purified compounds
Solution Approach 2:
The process utilizes parameter changes in the chromatographic conditions, including solvent composition ratios, flow rates, and temperature variations, to optimize separation at each stage. By adjusting these parameters across different chromatography types, the system achieves high productivity while controlling operational complexity through standardized parameter modification protocols
3Manufacturing precision
If conventional extraction methods are used, then the process is straightforward, but the quality and purity of obtained compounds are insufficient
Solution Approach 1:
Multiple intermediary chromatographic media serve as purifiers in the sequence. Each medium selectively interacts with specific compound types through mechanisms such as adsorption, gel filtration, and size exclusion, thereby enhancing compound purity while distributing the purification burden across multiple simpler steps rather than a single complex process
Solution Approach 2:
The process replaces simple mechanical filtration with sophisticated chromatographic separation mechanisms including adsorption on macroporous resins, gel filtration based on molecular size and shape, and affinity chromatography. These substitutions enable high-purity compound isolation while managing complexity through well-established chromatographic techniques rather than inventing new separation mechanisms
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Smilaxchinoside F shows significant inhibition effects on SPA and ECV-304 cells, indicating its potential in treating angiogenesis-related diseases with clear dose-effect and time-effect relationships, offering a promising application in medicine for conditions like diabetic retinopathy, atherosclerosis, and tumor diseases.
Implementation Method 1
The crude powder of Smilax china roots is extracted by organic solvents; the extraction liquid are combined; and then the organic solvents are recovered
Implementation Method 2
the n-butanol extracts are adsorbed by DM130 macroporous resins, eluted with water, 25%, 50% and 75% of ethanol, respectively
Implementation Method 3
50% elution fraction of the n-butanol extracts are adsorbed by MCI gel filtration chromatography and 100 ̃300 mesh silica gel column chromatography
Implementation Method 4
the fraction 7 to 9 are purified by Sephadex LH-20 gel filtration chromatography and are crystallized repeatedly to obtain Smilaxchinoside F compound
Implementation Method 5
the fraction 7 to 9 are purified by Sephadex LH-20 gel filtration chromatography and are crystallized repeatedly to obtain Smilaxchinoside F compound
Data Source
AI summary
Smilaxchinoside F compound and its separation method are disclosed. The compound has the structure as following. The use of Smilaxchinoside F in the manufacture of a medicine for treating abnormal angiogenesis and its relating diseases is also disclosed.